Expression levels of IQGAP3 in tissue and urine samples from bladder cancer patients are significantly higher than those in samples from control groups [19,20], and IQGAP3 was upregulated by CDC42 activation of the Ras/ERK pathway, promoting the development of bladder cancer [20]. This evidence concerns the gene CDC42 and urinary bladder carcinoma.